Insulin Receptor Substrate 1 Gene Variation Modifies Insulin Resistance Response to Weight-loss Diets in a 2-year Randomized Trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) Trial

Overview

Journal Circulation

Specialty Cardiology & Vascular Diseases

Date 2011 Jul 13

PMID 21747052

Citations 64

Authors

Qibin Qi

George A Bray

Steven R Smith

Frank B Hu

Frank M Sacks

Lu Qi

Affiliations

Soon will be listed here.

Abstract

Background: Common genetic variants in the insulin receptor substrate 1 (IRS1) gene have been recently associated with insulin resistance and hyperinsulinemia. We examined whether the best-associated variant modifies the long-term changes in insulin resistance and body weight in response to weight-loss diets in Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial.

Methods And Results: We genotyped IRS1 rs2943641 in 738 overweight adults (61% were women) who were randomly assigned to 1 of 4 diets varying in macronutrient contents for 2 years. We assessed the progress in fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR) and weight loss by genotypes. At 6 months, participants with the risk-conferring CC genotype had greater decreases in insulin (P=0.009), HOMA-IR (P=0.015), and weight loss (P=0.018) than those without this genotype in the highest-carbohydrate diet group whereas an opposite genotype effect on changes in insulin and HOMA-IR (P≤0.05) was observed in participants assigned to the lowest-carbohydrate diet group. No significant differences were observed across genotypes in the other 2 diet groups. The tests for genotype by intervention interactions were all significant (P<0.05). At 2 years, the genotype effect on changes in insulin and HOMA-IR remained significant in the highest-carbohydrate diet group (P<0.05). The highest carbohydrate diet led to a greater improvement of insulin and HOMA-IR (P for genotype-time interaction ≤0.009) in participants with the CC genotype than those without this genotype across 2-year intervention.

Conclusions: Individuals with the IRS1 rs2943641 CC genotype might obtain more benefits in weight loss and improvement of insulin resistance than those without this genotype by choosing a high-carbohydrate and low-fat diet.

Clinical Trial Registration: http:www.clinicaltrials.gov. Unique identifier: NCT00072995.

Citing Articles

Using Metabolic Testing to Personalize Behavioral Obesity Treatment.

Epstein L, Apolzan J, Moore M, Neuwald N, Faith M Obes Sci Pract. 2025; 11(2):e70065.

PMID: 40070464 PMC: 11894463. DOI: 10.1002/osp4.70065.

Machine-learning approaches to predict individualized treatment effect using a randomized controlled trial.

Hamaya R, Hara K, Manson J, Rimm E, Sacks F, Xue Q Eur J Epidemiol. 2025; .

PMID: 39946045 DOI: 10.1007/s10654-024-01185-7.

Combined effects of genetic background and diet on mouse metabolism and gene expression.

Reed J, Hasan F, Karkar A, Banka D, Hinkle J, Shastri P iScience. 2024; 27(12):111323.

PMID: 39640571 PMC: 11617257. DOI: 10.1016/j.isci.2024.111323.

Exploring the Interplay of Genetics and Nutrition in the Rising Epidemic of Obesity and Metabolic Diseases.

Gorczynska-Kosiorz S, Kosiorz M, Dziegielewska-Gesiak S Nutrients. 2024; 16(20).

PMID: 39458556 PMC: 11510173. DOI: 10.3390/nu16203562.

Is There an Ideal Diet? Some Insights from the POUNDS Lost Study.

Bray G, Qi L, Sacks F Nutrients. 2024; 16(14.

PMID: 39064800 PMC: 11280300. DOI: 10.3390/nu16142358.

References

Shai I, Schwarzfuchs D, Henkin Y, Shahar D, Witkow S, Greenberg I . Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008; 359(3):229-41. DOI: 10.1056/NEJMoa0708681. View

Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T . Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 1994; 372(6502):182-6. DOI: 10.1038/372182a0. View

Yancy Jr W, Olsen M, Guyton J, Bakst R, Westman E . A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004; 140(10):769-77. DOI: 10.7326/0003-4819-140-10-200405180-00006. View

Wood R, Fernandez M . Carbohydrate-restricted versus low-glycemic-index diets for the treatment of insulin resistance and metabolic syndrome. Nutr Rev. 2009; 67(3):179-83. DOI: 10.1111/j.1753-4887.2009.00186.x. View

Dresner A, Laurent D, Marcucci M, Griffin M, Dufour S, Cline G . Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest. 1999; 103(2):253-9. PMC: 407880. DOI: 10.1172/JCI5001. View

Sacks F, Bray G, Carey V, Smith S, Ryan D, Anton S . Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009; 360(9):859-73. PMC: 2763382. DOI: 10.1056/NEJMoa0804748. View

Frangioudakis G, Ye J, Cooney G . Both saturated and n-6 polyunsaturated fat diets reduce phosphorylation of insulin receptor substrate-1 and protein kinase B in muscle during the initial stages of in vivo insulin stimulation. Endocrinology. 2005; 146(12):5596-603. DOI: 10.1210/en.2005-0481. View

Reaven G, Abbasi F, McLaughlin T . Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res. 2004; 59:207-23. DOI: 10.1210/rp.59.1.207. View

Kirk E, Reeds D, Finck B, Mayurranjan S, Mayurranjan M, Patterson B . Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology. 2009; 136(5):1552-60. PMC: 2677125. DOI: 10.1053/j.gastro.2009.01.048. View

10.

Lopez-Miranda J, Perez-Martinez P, Marin C, Fuentes F, Delgado J, Perez-Jimenez F . Dietary fat, genes and insulin sensitivity. J Mol Med (Berl). 2006; 85(3):213-26. DOI: 10.1007/s00109-006-0138-1. View

11.

Araki E, Lipes M, Patti M, Bruning J, Haag 3rd B, Johnson R . Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 1994; 372(6502):186-90. DOI: 10.1038/372186a0. View

12.

Manco M, Mingrone G . Effects of weight loss and calorie restriction on carbohydrate metabolism. Curr Opin Clin Nutr Metab Care. 2005; 8(4):431-9. DOI: 10.1097/01.mco.0000172585.09762.8e. View

13.

Purnell J . Obesity: Calories or content: what is the best weight-loss diet?. Nat Rev Endocrinol. 2009; 5(8):419-20. DOI: 10.1038/nrendo.2009.145. View

14.

Marin C, Perez-Martinez P, Delgado-Lista J, Gomez P, Rodriguez F, Yubero-Serrano E . The insulin sensitivity response is determined by the interaction between the G972R polymorphism of the insulin receptor substrate 1 gene and dietary fat. Mol Nutr Food Res. 2010; 55(2):328-35. DOI: 10.1002/mnfr.201000235. View

15.

Griffin M, Marcucci M, Cline G, Bell K, Barucci N, Lee D . Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 1999; 48(6):1270-4. DOI: 10.2337/diabetes.48.6.1270. View

16.

Dansinger M, Gleason J, Griffith J, Selker H, Schaefer E . Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005; 293(1):43-53. DOI: 10.1001/jama.293.1.43. View

17.

Foster G, Wyatt H, Hill J, McGuckin B, Brill C, Mohammed B . A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003; 348(21):2082-90. DOI: 10.1056/NEJMoa022207. View

18.

Gardner C, Kiazand A, Alhassan S, Kim S, Stafford R, Balise R . Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007; 297(9):969-77. DOI: 10.1001/jama.297.9.969. View

19.

Kahn S, Hull R, Utzschneider K . Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006; 444(7121):840-6. DOI: 10.1038/nature05482. View

20.

Katan M . Weight-loss diets for the prevention and treatment of obesity. N Engl J Med. 2009; 360(9):923-5. DOI: 10.1056/NEJMe0810291. View